Abstract
Objective. To determine the frequency of erysipelas and the frequency of carbohydrate metabolism disorders in patients of the purulent–septic centre in Zaporizhzhya.
Materials and methods. We analysed 15 612 case histories of patients with purulent–septic diseases treated at the purulent–septic centre in Zaporizhzhia in 2003–2023.
Results. It was found that 359 (2.3%) patients had erysipelas inflammation in the setting of type 1 or type 2 diabetes mellitus. Destructive forms of erysipelas were recorded in 315 (87.7%) patients, in 30 (9.5%) of them the disease was complicated by sepsis. In uncomplicated forms of erysipelas, diabetes mellitus was observed in 29 (65.9%) patients, and in destructive forms – in 246 (78.1%).
Conclusions. Patients with diabetes mellitus have a significantly higher risk of developing septic complications than patients without carbohydrate metabolism disorders.
Reference10 articles.
1. Mykychak IV, Tovkai OA, Globa EV, Honcharova OA, Zelinska NB, Komisarenko YuI, et al. Diabetes mellitus: an evidence–based clinical guideline. [Internet]. Kyiv; 2022. 347 p. Ukrainian. Available from: https://www.dec.gov.ua/wp–content/uploads/2023/01/2023_nastanova–czd_dorosli.pdf.
2. Holubovska OA, editor. Infectious diseases: textbook. 4th edition. Kyiv: Medicine; 2022. 464 p. Ukrainian. ISBN: 978–617–505–909–8.
3. Michael Y, Shaukat NM. Erysipelas. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. Аvailable from: https://www.ncbi.nlm.nih.gov/books/NBK532247/
4. Haire–Joshu D, Hill–Briggs F. The Next Generation of Diabetes Translation: A Path to Health Equity. Annu Rev Public Health. 2019 Apr 1;40:391–410. doi: 10.1146/annurev–publhealth–040218–044158. Epub 2019 Jan 2. PMID: 30601723.
5. Huang YF, Tang HJ, Hsu HL. The Impact of Monthly Prophylactic Antibiotics Use in Patients with Recurrent Cellulitis: A 20–Year Population–Based Cohort Study in a Medical Center. Infect Drug Resist. 2023 Jun 15;16:3819–27. doi: 10.2147/IDR.S393919. PMID: 37342433; PMCID: PMC10278657.